logo
Search orAI Icon𝛼SK
ENTITY

VISEN Pharmaceuticals (2561 HK)

9
Analysis
Health Care • China
VISEN Pharmaceuticals develops biopharmaceutical technology focused on treatments in selected endocrinology diseases. The Company provides lonapegsomatropin, navepegritide, palopegteriparatide, and other treatments. VISEN Pharmaceuticals conducts businesses in China.
more
SparkleRequest Primer
Publication Icon
No publications yet
No AI primers are available right now. Create one using Smartkarma AI.
Back to "All"

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.59.7

x